Jennifer A Unger1, Daniel Matemo, Jillian Pintye, Alison Drake, John Kinuthia, R Scott McClelland, Grace John-Stewart. 1. From the *Department of Obstetrics and Gynecology, University of Washington, Seattle, WA; †Department of Research & Programs, Kenyatta National Hospital, Nairobi, Kenya; Departments of ‡Global Health, §Medicine, and ¶Epidemiology, University of Washington, Seattle, WA; ∥Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya; and **Department of Pediatrics, University of Washington, Seattle, WA.
Abstract
BACKGROUND: Patient-delivered partner treatment (PDPT) for sexually transmitted infections (STIs) increases rates of partner treatment and decreases reinfection, but has not been evaluated during pregnancy. METHODS: This prospective cohort was nested within a larger study of peripartum HIV acquisition. Participants with microbiologic diagnosis of Chlamydia trachomatis, Neisseria gonorrhoeae, and/or Trichomonas vaginalis were screened for participation. Questionnaires were administered to determine PDPT acceptability and barriers. Women were reassessed at least 30 days to determine partner treatment and reinfection. Women whose partners did or did not receive PDPT were compared. RESULTS: One hundred twelve (22.2%) women in the parent cohort had a treatable STI; 78 within the PDPT study period, of whom 66 were eligible and 59 (89.3%) accepted PDPT. Fifty-one women had PDPT outcome data, 37 (73%) of whom reported partners treated with PDPT. Fourteen women (27%) refused or did not deliver partner treatment. Median age was 22 years (interquartile range, 20-26 years) and 88% were married. Compared with women who delivered PDPT, those who did not were more likely to have a partner living far away (23% vs. 0%, P = 0.004) and to report current intimate partner violence (14% vs. 0%, P = 0.02). Reported PDPT barriers included fear of partner's anger/abuse (5%) and accusations of being STI source (5%). CONCLUSION: Patient-delivered partner treatment was acceptable and feasible for pregnant/postpartum Kenyan women and may reduce recurrent STIs in pregnancy.
BACKGROUND:Patient-delivered partner treatment (PDPT) for sexually transmitted infections (STIs) increases rates of partner treatment and decreases reinfection, but has not been evaluated during pregnancy. METHODS: This prospective cohort was nested within a larger study of peripartum HIV acquisition. Participants with microbiologic diagnosis of Chlamydia trachomatis, Neisseria gonorrhoeae, and/or Trichomonas vaginalis were screened for participation. Questionnaires were administered to determine PDPT acceptability and barriers. Women were reassessed at least 30 days to determine partner treatment and reinfection. Women whose partners did or did not receive PDPT were compared. RESULTS: One hundred twelve (22.2%) women in the parent cohort had a treatable STI; 78 within the PDPT study period, of whom 66 were eligible and 59 (89.3%) accepted PDPT. Fifty-one women had PDPT outcome data, 37 (73%) of whom reported partners treated with PDPT. Fourteen women (27%) refused or did not deliver partner treatment. Median age was 22 years (interquartile range, 20-26 years) and 88% were married. Compared with women who delivered PDPT, those who did not were more likely to have a partner living far away (23% vs. 0%, P = 0.004) and to report current intimate partner violence (14% vs. 0%, P = 0.02). Reported PDPT barriers included fear of partner's anger/abuse (5%) and accusations of being STI source (5%). CONCLUSION:Patient-delivered partner treatment was acceptable and feasible for pregnant/postpartum Kenyan women and may reduce recurrent STIs in pregnancy.
Authors: Catherine L Haggerty; Sami L Gottlieb; Brandie D Taylor; Nicola Low; Fujie Xu; Roberta B Ness Journal: J Infect Dis Date: 2010-06-15 Impact factor: 5.226
Authors: Matthew R Golden; William L H Whittington; H Hunter Handsfield; James P Hughes; Walter E Stamm; Matthew Hogben; Agnes Clark; Cheryl Malinski; Jennifer R L Helmers; Katherine K Thomas; King K Holmes Journal: N Engl J Med Date: 2005-02-17 Impact factor: 91.245
Authors: Patricia Kissinger; Norine Schmidt; Hamish Mohammed; Jami S Leichliter; Thomas L Gift; Bernadette Meadors; Cheryl Sanders; Thomas A Farley Journal: Sex Transm Dis Date: 2006-07 Impact factor: 2.830
Authors: Christina B Hosenfeld; Kimberly A Workowski; Stuart Berman; Akbar Zaidi; Jeri Dyson; Debra Mosure; Gail Bolan; Heidi M Bauer Journal: Sex Transm Dis Date: 2009-08 Impact factor: 2.830
Authors: Sophia Taleghani; Dvora Joseph-Davey; Scott B West; Henry J Klausner; Adriane Wynn; Jeffrey D Klausner Journal: Int J STD AIDS Date: 2018-11-05 Impact factor: 1.359
Authors: Jayalakshmi Ravindran; Barbra A Richardson; John Kinuthia; Jennifer A Unger; Alison L Drake; Lusi Osborn; Daniel Matemo; Janna Patterson; R Scott McClelland; Grace John-Stewart Journal: J Infect Dis Date: 2021-12-15 Impact factor: 5.226
Authors: Simon Chengo Masha; Elizabeth Wahome; Mario Vaneechoutte; Piet Cools; Tania Crucitti; Eduard J Sanders Journal: PLoS One Date: 2017-03-31 Impact factor: 3.240
Authors: Yunia Mayanja; Aggrey David Mukose; Susan Nakubulwa; Gloria Omosa-Manyonyi; Anatoli Kamali; David Guwatudde Journal: PLoS One Date: 2016-05-12 Impact factor: 3.752
Authors: Jodie Dionne-Odom; Akila Subramaniam; Kristal J Aaron; William M Geisler; Alan T N Tita; Jeanne Marrazzo Journal: Am J Obstet Gynecol MFM Date: 2020-08-18